Yale researchers enroll first patient in study of heart-preserving molecule

July 24, 2012 By Karen N. Peart

(Medical Xpress) -- A 69-year-old man became the first patient enrolled and treated in an ongoing study at Yale School of Medicine of BB3, a molecule that promises to preserve heart muscle, promote healing and improve clinical outcomes in heart attack patients.

BB3 mimics the effects of hepatocyte growth factor, which appears to act as a modulator of . During a heart attack, the blood supply to part of the heart is interrupted, causing the surrounding to die and impair heart function. The amount of heart muscle that is lost and the nature of the repair process after the heart attack determine the eventual function of the damaged heart, and thus the quality of life of the patient.

Pre-clinical studies showed that following a heart attack, BB3 has the ability to not only prevent the death of affected , but to promote a healthy and adaptive repair process.

“We believe BB3 to be a promising therapy for the treatment of acute myocardial infarction,” said Dr. Frank Giordano, associate professor of medicine at Yale School of Medicine, and principal investigator at Yale-New Haven Hospital. “The trial will provide valuable data not only on the safety of BB3 in this population, but also whether this molecule can preserve , promote beneficial healing of the heart, and improve clinical outcomes in patients with acute myocardial infarction.

The Phase II double-blind, placebo-controlled multicenter trial is evaluating the safety and efficacy of BB3 in conjunction with routine care to improve heart function in patients who have experienced a first attack. The target enrollment is 80 patients who will be randomly assigned to receive BB3 or a placebo.

Patients between the ages of 21 and 80 who have had their first heart attack are potential candidates for this study, which is actively recruiting at Yale.

“While it is not known whether the first enrolled patient received BB3 or a placebo treatment, he is now home, doing well, and will receive careful follow up to evaluate his and response to treatment,” said Giordano.

Explore further: Stem cells from cord blood could help repair damaged heart muscle

More information: For more information or to enroll in the study, call 203-737-8320 or 203-737-2213.

Related Stories

Stem cells from cord blood could help repair damaged heart muscle

October 13, 2011
(Medical Xpress) -- New research has found that stem cells derived from human cord blood could be an effective alternative in repairing heart attacks.

Helping the heart help itself: Research points to new use for stem cells

April 8, 2011
(PhysOrg.com) -- Human trials of stem cell therapy for post-heart attack patients have raised as many questions as they have answered -- because while the patients have tended to show some improvement in heart function, the ...

Recommended for you

Hormone therapy in the menopause transition did not increase stroke risk

November 24, 2017
Postmenopausal hormone therapy is not associated with increased risk of stroke, provided that it is started early, according to a report from Karolinska Institutet published in the journal PLOS Medicine.

Low-salt and heart-healthy dash diet as effective as drugs for some adults with high blood pressure

November 22, 2017
A study of more than 400 adults with prehypertension, or stage 1 high blood pressure, found that combining a low-salt diet with the heart-healthy DASH diet substantially lowers systolic blood pressure—the top number in ...

Stroke patients may have more time to get treatment, study finds

November 22, 2017
Patients and doctors long have relied on a simple rule of thumb for seeking care after an ischemic stroke: "Time is brain."

Cases of heart failure continue to rise; poorest people worst affected

November 22, 2017
The number of people being diagnosed with heart failure in the UK continues to rise as a result of demographic changes common to many developed countries, new research by The George Institute for Global Health at the University ...

Some cancer therapies may provide a new way to treat high blood pressure

November 20, 2017
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators. The finding could offer a real advance in hypertension treatment ...

Could this protein protect people against coronary artery disease?

November 17, 2017
The buildup of plaque in the heart's arteries is an unfortunate part of aging. But by studying the genetic makeup of people who maintain clear arteries into old age, researchers led by UNC's Jonathan Schisler, PhD, have identified ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.